RARE MDS/MPN OVERLAP: WHEN JAK2 V617F MEETS DEL(5Q) MUTATION

被引：0
|
作者：
Rupoli, S. [1 ]
Morsia, E. [2 ]
Goteri, G. [2 ,3 ]
Capelli, D. [1 ]
Scortechini, A. R. [1 ]
Poloni, A. [1 ,2 ]
Micucci, G. [2 ]
Garvey, K. B. [2 ]
Ceglie, S. [2 ]
Fiorentini, A. [2 ]
Angelini, M. [4 ]
Mancini, S. [5 ]
Discepoli, G. [6 ]
Viola, N. [7 ]
Olivieri, A. [1 ,2 ]
机构：
[1] Osped Riuniti Ancona, Clin Ematol, Ancona, Italy
[2] Univ Politecn Marche, Ancona, Italy
[3] Osped Riuniti Ancona, Anat Patol, Ancona, Italy
[4] Osped Mazzoni Ascoli Piceno, Lab Biol Mol, Ascoli Piceno, Italy
[5] Osped Riuniti Ancona, Lab Biol Mol, Ancona, Italy
[6] Osped Riuniti Ancona, Lab Citogenet, Ancona, Italy
[7] Osped Riuniti Ancona, Lab Citofluorimetria, Ancona, Italy
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PU40
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [1] Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation
    Azaceta, Gemma
    Calasanz, Maria J.
    Dourdil, Victoria
    Bonafonte, Elena
    Izquierdo, Isabel
    Palomera, Luis
    LEUKEMIA & LYMPHOMA, 2010, 51 (10) : 1941 - 1943
  • [2] The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow
    W Ingram
    N C Lea
    J Cervera
    U Germing
    P Fenaux
    B Cassinat
    J J Kiladjian
    J Varkonyi
    P Antunovic
    N B Westwood
    M J Arno
    A Mohamedali
    J Gaken
    T Kontou
    B H Czepulkowski
    N A Twine
    J Tamaska
    J Csomer
    S Benedek
    N Gattermann
    E Zipperer
    A Giagounidis
    Z Garcia-Casado
    G Sanz
    G J Mufti
    Leukemia, 2006, 20 : 1319 - 1321
  • [3] The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow
    Ingram, W.
    Lea, N. C.
    Cervera, J.
    Germing, U.
    Fenaux, P.
    Cassinat, B.
    Kiladjian, J. J.
    Varkonyi, J.
    Antunovic, P.
    Westwood, N. B.
    Arno, M. J.
    Mohamedali, A.
    Gaken, J.
    Kontou, T.
    Czepulkowski, B. H.
    Twine, N. A.
    Tamaska, J.
    Csomer, J.
    Benedek, S.
    Gattermann, N.
    Zipperer, E.
    Giagounidis, A.
    Garcia-Casado, Z.
    Sanz, G.
    Mufti, G. J.
    LEUKEMIA, 2006, 20 (07) : 1319 - 1321
  • [4] Myeloid neoplasms with isolated del(5q) and JAK2 V617F mutation: a "grey zone" combination of myelodysplastic and myeloproliferative features?
    Sangiorgio, Valentina F. I.
    Geyer, Julia T.
    Margolskee, Elizabeth
    Al-Kawaaz, Mustafa
    Mathew, Susan
    Tam, Wayne
    Orazi, Attilio
    HAEMATOLOGICA, 2020, 105 (06) : E276 - E279
  • [5] JAK2 V617F mutation is infrequent in "5q-syndrorne" and 5q-associated MDS.
    Zhang, Ling
    Gueller, Saskia
    Raynaud, Sophie
    Koeffler, Phillip H.
    Lee, Stephen
    BLOOD, 2006, 108 (11) : 293B - 293B
  • [6] Neutrophilia and the JAK2 V617F Mutation
    Langabeer, Stephen E.
    Haslam, Karl
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 437 - 438
  • [7] Splenomegaly and the JAK2 V617F mutation
    Langabeer, Stephen E.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 37 : E45 - E46
  • [8] JAK2 V617F mutation is associated with 5q-syndrome in Chinese
    Wong, K. F.
    Wong, W. S.
    Siu, Lisa L. P.
    Lau, T. C.
    Chan, N. P.
    LEUKEMIA & LYMPHOMA, 2009, 50 (08) : 1333 - 1335
  • [9] JAK2V617F mutation in myelodysplastic syndrome (MDS) with del(5q) arises in genetically discordant clones
    Sokol, L.
    Caceres, G.
    Rocha, K.
    Stockero, K. J.
    Dewald, D. W.
    List, A. F.
    LEUKEMIA RESEARCH, 2010, 34 (06) : 821 - 823
  • [10] Aquagenic pruritus and the JAK2 V617F mutation
    Langabeer, S. E.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (03) : E33 - E33
12345